Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis.

Abstract

Excessive free-radical production due to various bacterial components released during bacterial infection has been linked to cell death and tissue injury. Peroxynitrite is a highly reactive oxidant produced by the combination of nitric oxide (NO) and superoxide anion, which has been implicated in cell death and tissue injury in various forms of critical illness. Pharmacological decomposition of peroxynitrite may represent a potential therapeutic approach in diseases associated with the overproduction of NO and superoxide. In the present study, we tested the effect of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis. Mice were injected i.p. with LPS 40 mg/kg with or without FP15 [Fe(III) tetrakis-2-(N-triethylene glycol monomethyl ether)pyridyl porphyrin] (0.1, 0.3, 1, 3, or 10 mg/kg per hour). Mice were killed 12 h later, followed by the harvesting of samples from the lung, liver, and gut for malondialdehyde and myeloperoxidase measurements. In other subsets of animals, blood samples were obtained by cardiac puncture at 1.5, 4, and 8 h after LPS administration for cytokine (TNF-α, IL-1β, and IL-10), nitrite/nitrate, alanine aminotransferase, and blood urea nitrogen measurements. Endotoxemic animals showed an increase in survival from 25% to 80% at the FP15 doses of 0.3 and 1 mg/kg per hour. The same dose of FP15 had no effect on plasma levels of nitrite/nitrate. There was a reduction in liver and lung malondialdehyde in the endotoxemic animals pretreated with FP15, as well as in hepatic myeloperoxidase and biochemical markers of liver and kidney damage (alanine aminotransferase and blood urea nitrogen). In a bacterial model of sepsis induced by cecal ligation and puncture, FP15 treatment (0.3 mg/kg per day) significantly protected against mortality. The current data support the view that peroxynitrite is a critical factor mediating liver, gut, and lung injury in endotoxemia and septic shock: its pharmacological neutralization may be of therapeutic benefit.

• Authors: Francisco Garcia Soriano, Clara Batista Lorigados, Pal Pacher, Csaba Szabó
• Journal: Shock (Augusta, Ga.) (Shock) Vol. 35 Issue 6 Pg. 560-6 (Jun 2011) ISSN: 1540-0514 [Electronic] United States
• PMID: 21263378 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin
• Lipopolysaccharides
• Metalloporphyrins
• Nitrates
• Nitrites
• Peroxynitrous Acid
• Malondialdehyde
• Peroxidase

Topics

• Animals
• Endotoxemia (drug therapy)
• Lipopolysaccharides
• Malondialdehyde (metabolism)
• Metalloporphyrins (pharmacology, therapeutic use)
• Mice
• Nitrates (blood)
• Nitrites (blood)
• Peroxidase (metabolism)
• Peroxynitrous Acid (adverse effects, metabolism)
• Sepsis (drug therapy, physiopathology)